Back
RenovoRx Vs. MiNK Therapeutics Industry Stock Comparison
Sell
34
RNXT
RenovoRx
Last Price:
1.24
Seasonality Move:
-10.63%
Sell
32
INKT
MiNK Therapeutics
Last Price:
0.97
Seasonality Move:
-22.44%
Sell
34
RenovoRx (RNXT)
is a Sell
Is RenovoRx a Buy, Sell or Hold?
- The current RenovoRx [RNXT] share price is $1.22. The Score for RNXT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- RNXT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics (INKT)
is a Sell
Is MiNK Therapeutics a Buy, Sell or Hold?
- The current MiNK Therapeutics [INKT] share price is $0.98. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNXT Stock Price Chart
INKT Stock Price Chart
What is MiNK Therapeutics's stock price today?
-
The MiNK Therapeutics share price today is $0.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INKT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 46.86 | Sell |
| Chaikin Money Flow: | -22307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.17 - 1.25) | Buy |
| Bollinger Bands (100): | (1.03 - 1.61) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 52.13 | Buy |
| Chaikin Money Flow: | 16969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.83 - 1.15) | Sell |
| Bollinger Bands (100): | (0.86 - 1.06) | Buy |
RNXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.22 | Sell |
| 20-day SMA: | 1.21 | Buy |
| 50-day SMA: | 1.37 | Sell |
| 200-day SMA: | 1.33 | Sell |
| 8-day EMA: | 1.22 | Sell |
| 20-day EMA: | 1.24 | Sell |
| 50-day EMA: | 1.29 | Sell |
| 200-day EMA: | 1.48 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.94 | Buy |
| 20-day SMA: | 0.95 | Buy |
| 50-day SMA: | 0.96 | Buy |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.95 | Buy |
| 20-day EMA: | 0.95 | Buy |
| 50-day EMA: | 0.96 | Buy |
| 200-day EMA: | 1.21 | Sell |
RenovoRx Earnings Growth & RNXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
MiNK Therapeutics Earnings Growth & INKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.05 per share.
RenovoRx Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||